323 related articles for article (PubMed ID: 34940364)
1. Alzheimer's Disease: Current Perspectives and Advances in Physiological Modeling.
Josephine Boder E; Banerjee IA
Bioengineering (Basel); 2021 Dec; 8(12):. PubMed ID: 34940364
[TBL] [Abstract][Full Text] [Related]
2. Modeling Alzheimer's Disease Using Human Brain Organoids.
Karmirian K; Holubiec M; Goto-Silva L; Fernandez Bessone I; Vitória G; Mello B; Alloatti M; Vanderborght B; Falzone TL; Rehen S
Methods Mol Biol; 2023; 2561():135-158. PubMed ID: 36399268
[TBL] [Abstract][Full Text] [Related]
3. Beyond animal models: revolutionizing neurodegenerative disease modeling using 3D in vitro organoids, microfluidic chips, and bioprinting.
Teli P; Kale V; Vaidya A
Cell Tissue Res; 2023 Oct; 394(1):75-91. PubMed ID: 37572163
[TBL] [Abstract][Full Text] [Related]
4. Patient-derived iPSCs, a reliable
Amponsah AE; Guo R; Kong D; Feng B; He J; Zhang W; Liu X; Du X; Ma Z; Liu B; Ma J; Cui H
Rev Neurosci; 2021 Jun; 32(4):379-402. PubMed ID: 33550785
[TBL] [Abstract][Full Text] [Related]
5. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
Machairaki V
Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
[TBL] [Abstract][Full Text] [Related]
6. The Breakthroughs and Caveats of Using Human Pluripotent Stem Cells in Modeling Alzheimer's Disease.
Sahlgren Bendtsen KM; Hall VJ
Cells; 2023 Jan; 12(3):. PubMed ID: 36766763
[TBL] [Abstract][Full Text] [Related]
7. Current progress of cerebral organoids for modeling Alzheimer's disease origins and mechanisms.
Sreenivasamurthy S; Laul M; Zhao N; Kim T; Zhu D
Bioeng Transl Med; 2023 Mar; 8(2):e10378. PubMed ID: 36925717
[TBL] [Abstract][Full Text] [Related]
8. Human Induced Pluripotent Stem Cells and the Modelling of Alzheimer's Disease: The Human Brain Outside the Dish.
Tong G; Izquierdo P; Raashid RA
Open Neurol J; 2017; 11():27-38. PubMed ID: 29151989
[TBL] [Abstract][Full Text] [Related]
9. Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer's disease.
Marei HE; Khan MUA; Hasan A
Cell Mol Biol Lett; 2023 Nov; 28(1):98. PubMed ID: 38031028
[TBL] [Abstract][Full Text] [Related]
10. Modeling and Targeting Alzheimer's Disease With Organoids.
Papaspyropoulos A; Tsolaki M; Foroglou N; Pantazaki AA
Front Pharmacol; 2020; 11():396. PubMed ID: 32300301
[TBL] [Abstract][Full Text] [Related]
11. Mouse induced pluripotent stem cells-derived Alzheimer's disease cerebral organoid culture and neural differentiation disorders.
Fan W; Sun Y; Shi Z; Wang H; Deng J
Neurosci Lett; 2019 Oct; 711():134433. PubMed ID: 31421155
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's in a dish - induced pluripotent stem cell-based disease modeling.
de Leeuw S; Tackenberg C
Transl Neurodegener; 2019; 8():21. PubMed ID: 31338163
[TBL] [Abstract][Full Text] [Related]
13. Retinal and Brain Organoids: Bridging the Gap Between
Brighi C; Cordella F; Chiriatti L; Soloperto A; Di Angelantonio S
Front Neurosci; 2020; 14():655. PubMed ID: 32625060
[TBL] [Abstract][Full Text] [Related]
14. 3D culture models of Alzheimer's disease: a road map to a "cure-in-a-dish".
Choi SH; Kim YH; Quinti L; Tanzi RE; Kim DY
Mol Neurodegener; 2016 Dec; 11(1):75. PubMed ID: 27938410
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's in 3D culture: challenges and perspectives.
D'Avanzo C; Aronson J; Kim YH; Choi SH; Tanzi RE; Kim DY
Bioessays; 2015 Oct; 37(10):1139-48. PubMed ID: 26252541
[TBL] [Abstract][Full Text] [Related]
16. Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.
Logan S; Arzua T; Canfield SG; Seminary ER; Sison SL; Ebert AD; Bai X
Compr Physiol; 2019 Mar; 9(2):565-611. PubMed ID: 30873582
[TBL] [Abstract][Full Text] [Related]
17. Advances in Recapitulating Alzheimer's Disease Phenotypes Using Human Induced Pluripotent Stem Cell-Based In Vitro Models.
Hasan MF; Trushina E
Brain Sci; 2022 Apr; 12(5):. PubMed ID: 35624938
[TBL] [Abstract][Full Text] [Related]
18. Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy.
Yang J; Li S; He XB; Cheng C; Le W
Mol Neurodegener; 2016 May; 11(1):39. PubMed ID: 27184028
[TBL] [Abstract][Full Text] [Related]
19. Modeling neurodegenerative diseases with cerebral organoids and other three-dimensional culture systems: focus on Alzheimer's disease.
Venkataraman L; Fair SR; McElroy CA; Hester ME; Fu H
Stem Cell Rev Rep; 2022 Feb; 18(2):696-717. PubMed ID: 33180261
[TBL] [Abstract][Full Text] [Related]
20. A systematic review for the development of Alzheimer's disease in
Prajapat M; Kaur G; Choudhary G; Pahwa P; Bansal S; Joshi R; Batra G; Mishra A; Singla R; Kaur H; Prabha PK; Patel AP; Medhi B
Front Aging Neurosci; 2023; 15():1296919. PubMed ID: 38173557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
